Literature DB >> 19251089

Immunohistochemical detection of changes in tumor hypoxia.

James Russell1, Sean Carlin, Sean A Burke, Bixiu Wen, Kwang Mo Yang, C Clifton Ling.   

Abstract

PURPOSE: Although hypoxia is a known prognostic factor, its effect will be modified by the rate of reoxygenation and the extent to which the cells are acutely hypoxic. We tested the ability of exogenous and endogenous markers to detect reoxygenation in a xenograft model. Our technique might be applicable to stored patient samples. METHODS AND MATERIALS: The human colorectal carcinoma line, HT29, was grown in nude mice. Changes in tumor hypoxia were examined by injection of pimonidazole, followed 24 hours later by EF5. Cryosections were stained for these markers and for carbonic anhydrase IX (CAIX) and hypoxia-inducible factor 1alpha (HIF1alpha). Tumor hypoxia was artificially manipulated by carbogen exposure.
RESULTS: In unstressed tumors, all four markers showed very similar spatial distributions. After carbogen treatment, pimonidazole and EF5 could detect decreased hypoxia. HIF1alpha staining was also decreased relative to CAIX, although the effect was less pronounced than for EF5. Control tumors displayed small regions that had undergone spontaneous changes in tumor hypoxia, as judged by pimonidazole relative to EF5; most of these changes were reflected by CAIX and HIF1alpha.
CONCLUSION: HIF1alpha can be compared with either CAIX or a previously administered nitroimidazole to provide an estimate of reoxygenation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251089      PMCID: PMC2680715          DOI: 10.1016/j.ijrobp.2008.12.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  56 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

2.  Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

Authors:  A Fyles; M Milosevic; D Hedley; M Pintilie; W Levin; L Manchul; R P Hill
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 3.  Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays.

Authors:  J D Chapman; E L Engelhardt; C C Stobbe; R F Schneider; G E Hanks
Journal:  Radiother Oncol       Date:  1998-03       Impact factor: 6.280

4.  Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma.

Authors:  Hidehiro Kon-no; Genichiro Ishii; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Michiya Nara; Tomoki Fujii; Yukinori Murata; Hideaki Miyamoto; Atsushi Ochiai
Journal:  Lung Cancer       Date:  2006-10-09       Impact factor: 5.705

5.  A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy.

Authors:  M Nordsmark; J Overgaard
Journal:  Radiother Oncol       Date:  2000-10       Impact factor: 6.280

6.  Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.

Authors:  Laurence Goethals; Annelies Debucquoy; Christiaan Perneel; Karel Geboes; Nadine Ectors; Harlinde De Schutter; Freddy Penninckx; William H McBride; Adrian C Begg; Karin M Haustermans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-01       Impact factor: 7.038

7.  Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters.

Authors:  Hanneke W M van Laarhoven; Johan Bussink; Jasper Lok; Cornelis J A Punt; Arend Heerschap; Albert J van Der Kogel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

8.  Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Authors:  Toru Hiraga; Shinae Kizaka-Kondoh; Kiichi Hirota; Masahiro Hiraoka; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

9.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

10.  Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas.

Authors:  E A Griffiths; S A Pritchard; H R Valentine; N Whitchelo; P W Bishop; M P Ebert; P M Price; I M Welch; C M L West
Journal:  Br J Cancer       Date:  2006-12-19       Impact factor: 7.640

View more
  29 in total

1.  c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy.

Authors:  Fumihiro Sanada; Junghyun Kim; Anna Czarna; Noel Yan-Ki Chan; Sergio Signore; Barbara Ogórek; Kazuya Isobe; Ewa Wybieralska; Giulia Borghetti; Ada Pesapane; Andrea Sorrentino; Emily Mangano; Donato Cappetta; Chiara Mangiaracina; Mario Ricciardi; Maria Cimini; Emeka Ifedigbo; Mark A Perrella; Polina Goichberg; Augustine M Choi; Jan Kajstura; Toru Hosoda; Marcello Rota; Piero Anversa; Annarosa Leri
Journal:  Circ Res       Date:  2013-10-29       Impact factor: 17.367

2.  Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.

Authors:  Sandeep Apte; Frederick T Chin; Edward E Graves
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

3.  Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia.

Authors:  Hiroaki Kasashima; Masakazu Yashiro; Haruhito Kinoshita; Tatsunari Fukuoka; Tamami Morisaki; Go Masuda; Katsunobu Sakurai; Naoshi Kubo; Masaichi Ohira; Kosei Hirakawa
Journal:  Gastric Cancer       Date:  2015-06-23       Impact factor: 7.370

4.  Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.

Authors:  Nerissa Therese Viola-Villegas; Sean D Carlin; Ellen Ackerstaff; Kuntal K Sevak; Vadim Divilov; Inna Serganova; Natalia Kruchevsky; Michael Anderson; Ronald G Blasberg; Oleg A Andreev; Donald M Engelman; Jason A Koutcher; Yana K Reshetnyak; Jason S Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-01       Impact factor: 11.205

Review 5.  Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.

Authors:  C Bayer; P Vaupel
Journal:  Strahlenther Onkol       Date:  2012-03-29       Impact factor: 3.621

6.  GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.

Authors:  Praveen K Gulaka; Federico Rojas-Quijano; Zoltan Kovacs; Ralph P Mason; A Dean Sherry; Vikram D Kodibagkar
Journal:  J Biol Inorg Chem       Date:  2013-11-27       Impact factor: 3.358

7.  Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model.

Authors:  Kwang Mo Yang; James Russell; Mihaela E Lupu; Hyungjoon Cho; Xiao-Feng Li; Jason A Koutcher; C Clifton Ling
Journal:  Cancer Biol Ther       Date:  2009-10-22       Impact factor: 4.742

8.  Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET.

Authors:  Kelin Wang; Ellen Yorke; Sadek A Nehmeh; John L Humm; C Clifton Ling
Journal:  Med Phys       Date:  2009-10       Impact factor: 4.071

Review 9.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

10.  A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.

Authors:  Sean Carlin; Hanwen Zhang; Megan Reese; Nicholas N Ramos; Qing Chen; Sally-Ann Ricketts
Journal:  J Nucl Med       Date:  2014-02-03       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.